Get started
MARKSANS PHARMA LTD.MARKSANS PHARMA LTD.MARKSANS PHARMA LTD.

MARKSANS PHARMA LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

MARKSANS chart

Key stats

Market capitalization
‪79.98 B‬INR
Dividend yield (indicated)
0.28%
Price to earnings Ratio (TTM)
21.75
Basic EPS (TTM)
7.15INR
Net income
‪2.66 B‬INR
Revenue
‪18.51 B‬INR
Shares float
‪204.48 M‬
Beta (1Y)
0.89

About MARKSANS PHARMA LTD.

Sector
Health Technology
CEO
Mark Bosco Saldanha
Headquarters
Mumbai
Website
marksanspharma.com
Employees (FY)
‪1.4 K‬
Founded
1992
ISIN
INE750C01026
FIGI
BBG000D7VQ16
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio includes tablets, hard capsules, soft gelatin capsules, oral liquids, and ointments. It operates through the following geographical segments: US and North America, Europe and UK, Australia and New Zealand, India, and Rest of World. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai, India.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MARKSANS is 178.75 INR — it has increased by 1.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange MARKSANS PHARMA LTD. stocks are traded under the ticker MARKSANS.
MARKSANS PHARMA LTD. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track MARKSANS PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MARKSANS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARKSANS PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
MARKSANS reached its all-time high on Jan 3, 2024 with the price of 179.10 INR, and its all-time low was 1.25 INR and was reached on May 18, 2012.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪1.40 K‬ employees. See our rating of the largest employees — is MARKSANS PHARMA LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MARKSANS PHARMA LTD. EBITDA is ‪4.58 B‬ INR, and current EBITDA margin is 18.99%. See more stats in MARKSANS PHARMA LTD. financial statements.